LINC-ROR and breast carcinoma: Another study indicated that in natural tamoxifen-resistant breast cancer cells (MDA-MB-231), the downregulation of linc-ROR could inhibit EMT and enhance sensibility to tamoxifen by increasing miR-205 expression and suppressing ZEB1 and ZEB2 [69].